Posttranslational Control of Lipogenesis in the Tumor Microenvironment
Overview
Oncology
Affiliations
Metabolic reprogramming of cancer cells within the tumor microenvironment typically occurs in response to increased nutritional, translation and proliferative demands. Altered lipid metabolism is a marker of tumor progression that is frequently observed in aggressive tumors with poor prognosis. Underlying these abnormal metabolic behaviors are posttranslational modifications (PTMs) of lipid metabolism-related enzymes and other factors that can impact their activity and/or subcellular localization. This review focuses on the roles of these PTMs and specifically on how they permit the re-wiring of cancer lipid metabolism, particularly within the context of the tumor microenvironment.
Zhang H, Li Y, Huang J, Shen L, Xiong Y Acta Pharm Sin B. 2024; 14(11):4717-4737.
PMID: 39664426 PMC: 11628863. DOI: 10.1016/j.apsb.2024.07.021.
Roles of posttranslational modifications in lipid metabolism and cancer progression.
Feng T, Zhang H, Zhou Y, Zhu Y, Shi S, Li K Biomark Res. 2024; 12(1):141.
PMID: 39551780 PMC: 11571667. DOI: 10.1186/s40364-024-00681-y.
Recent progress in gene therapy for familial hypercholesterolemia treatment.
Luo Y, Hou Y, Zhao W, Yang B iScience. 2024; 27(9):110641.
PMID: 39262805 PMC: 11387600. DOI: 10.1016/j.isci.2024.110641.
Chen J, Zhao D, Wang Y, Liu M, Zhang Y, Feng T Adv Sci (Weinh). 2024; 11(38):e2406333.
PMID: 38981044 PMC: 11481198. DOI: 10.1002/advs.202406333.
TRIM21-Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers.
Gong J, Liu Y, Wang W, He R, Xia Q, Chen L Adv Sci (Weinh). 2023; 10(29):e2302318.
PMID: 37587773 PMC: 10582465. DOI: 10.1002/advs.202302318.